BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 15288836)

  • 1. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
    Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
    Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral graft vs. host disease in children--treatment with topical tacrolimus ointment.
    Albert MH; Becker B; Schuster FR; Klein B; Binder V; Adam K; Nienhoff C; Führer M; Borkhardt A
    Pediatr Transplant; 2007 May; 11(3):306-11. PubMed ID: 17430488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease.
    Fricain JC; Sibaud V; Swetyenga N; Tabrizi R; Campana F; Taïeb A
    Br J Dermatol; 2007 Mar; 156(3):588-90. PubMed ID: 17300261
    [No Abstract]   [Full Text] [Related]  

  • 4. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
    Dilek I; Demirer T; Ustün C; Arat M; Koç H; Beksaç M; Erdi H; Anadolu R; Ozcan M; Ilhan O; Akan H
    Bone Marrow Transplant; 1998 Jun; 21(11):1159-61. PubMed ID: 9645582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease.
    Elad S; Or R; Resnick I; Shapira MY
    Transpl Int; 2003 Sep; 16(9):665-70. PubMed ID: 12768230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gran versus host disease with oral involvement: report of one case].
    Rojas A G; González G N; Venables G C; Araos H D
    Rev Med Chil; 2008 Dec; 136(12):1570-3. PubMed ID: 19350175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical cyclosporin A for treatment of oral chronic graft-versus-host disease.
    Epstein JB; Reece DE
    Bone Marrow Transplant; 1994 Jan; 13(1):81-6. PubMed ID: 8019458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus.
    Schmook T; Kraft J; Benninghoff B; Nindl I; Roewert J; Ulrich C; Stockfleth E
    Bone Marrow Transplant; 2005 Jul; 36(1):87-8. PubMed ID: 15895116
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic graft versus host disease of oral mucosa: review of available therapies.
    Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease.
    Epstein JB; Nantel S; Sheoltch SM
    Bone Marrow Transplant; 2000 Mar; 25(6):683-7. PubMed ID: 10734307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q; Dong M; Wang QM; Wen JY; Wu XY
    Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral graft-versus-host disease.
    Schubert MM; Correa ME
    Dent Clin North Am; 2008 Jan; 52(1):79-109, viii-ix. PubMed ID: 18154866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus in hematopoietic stem cell transplantation.
    Fortune K; Couriel D
    Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):835-41. PubMed ID: 19545215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budesonide: a novel treatment for oral chronic graft versus host disease.
    Elad S; Or R; Garfunkel AA; Shapira MY
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Mar; 95(3):308-11. PubMed ID: 12627101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo after hematopoietic cell transplantation: six cases and review of the literature.
    Sanli H; Akay BN; Arat M; Koçyigit P; Akan H; Beksac M; Ilhan O
    Dermatology; 2008; 216(4):349-54. PubMed ID: 18285686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report.
    Sánchez AR; Sheridan PJ; Rogers RS
    J Periodontol; 2004 Apr; 75(4):613-9. PubMed ID: 15152828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases.
    Epstein JB; Gorsky M; Epstein MS; Nantel S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jan; 91(1):56-61. PubMed ID: 11174572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methotrexate for treatment of graft versus host disease after allogeneic hematopoietic stem cell transplantation].
    Huang XJ; Jiang Q; Chen H; Xu LP; Liu DH; Chen YH; Han W; Zhang YC; Liu KY; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(16):1097-101. PubMed ID: 16029565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.